Herantis Pharma’s 2H & FY 2022 Report

Herantis Pharma Plc, an innovative biotech company developing new disease-modifying therapies for Parkinson’s disease, will release 2H & FY 2022 Report on Thursday, March 2, 2023, at 08:00 EET/ 07:00 CET.

Members of the Herantis’ Management team will hold a live webinar to provide more details on the 2H & FY 2022 Report with a live Q&A session (in English) at 10:00 EET / 9:00 CET on the same day.

Please join the webinar a few minutes in advance.

To register for this event you need a Zoom account.

00:36:00